Generic Drugmakers, Biotechs Develop Template Biosimilar Substitution Bill

Generic Line
Generic drugmakers have joined forces with the biotech industry to craft biosimilar substitution legislation in Washington State. They plan to use the bill as a template for similar drives across the country.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00